The stomach consists of 3 topographic (fundus, corpus, and antrum) and 2 functional (oxyntic and pyloric gland) areas. The oxyntic gland area, the hallmark of which is the oxyntic (oxys, Greek for acid) or parietal cell, comprises 80% of the organ. The pyloric gland area, the hallmark of which is the gastrin or G cell, comprises 20% of the organ. The gastric mucosa is a continuous epithelial layer folded into gastric pits. The oxyntic glands contain 7 types of cells: 1) mucous neck cells, which produce mucus and gastric lipase in dogs; and surface mucous cells, which are cytoprotective; 2) chief cells responsible for the secretion of pepsinogen and leptin; 
Histamine released from ECL cells acts via H 3 receptors to inhibit SST secretion.
The principal stimulants of acid secretion at the level of the parietal cell are Ach released from postganglionic enteric neurons (neurocrine); gastrin, released from antral G cells (hormonal); and histamine, released from oxyntic ECL cells (paracrine). Histamine, released from ECL cells, binds to H2 receptors that activate adenylate cyclase and generate adenosine 3´,5´-cyclic monophosphate (cAMP). Gastrin, released from G cells, binds to cholecystokinin-2 (CCK-2) receptors that activate phospholipase C to induce release of cytosolic calcium (Ca ++ ).
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Gastrin stimulates the parietal cell directly and indirectly by releasing histamine from ECL cells. 
LOCAL GASTRIC MUCOSAL DEFENSE MECHANISMS
Mucus-bicarbonate-phospholipid "barrier." The mucus-bicarbonate-phospholipid "barrier" is formed by mucus, gel, bicarbonate, and surfactant phospholipids and constitutes the first line of mucosal defense. 227 This unstirred layer retains the bicarbonate secreted by surface epithelial cells to maintain a neutral microenvironment (pH ~ 7.0) at the surface epithelial cells and prevents penetration of pepsin and thus proteolytic digestion of the surface epithelium. Mucus gel is cosecreted with low-molecular weight trefoil factor family peptides (TFFs). 228 TFF2
increases the viscosity of gastric mucin and stabilizes the gel network. Ulcerogenic substances such as aspirin and bile salts cause dissipation of the mucus gel and phospholipid layer, leading to acid back-diffusion and mucosal injury. 227 The secretion of HCO3 -into a stable, adherent mucus gel layer creates a pH gradient at the epithelial surface in the stomach and duodenum, and provides the first line of mucosal defense against luminal acid. When the mucus bicarbonate barrier is overwhelmed or breaks down in disease, the next series of protective mechanisms comes into play, including intracellular neutralization of acid, rapid epithelial repair, and maintenance and distribution of mucosal blood flow.
Surface epithelial cells. The next line of mucosal defense is formed by a continuous layer of surface epithelial cells which secrete mucus and bicarbonate and generate PGs, heat shock proteins, TFFs, and cathelocidins. Cathelocidins and ß defensins are cationic peptides that play roles in the innate defensive system at mucosal surfaces preventing bacterial colonization.
Continuous cell renewal from mucosal progenitor cells. Complete replacement of the gastric
surface epithelium usually takes 3-7 days, whereas months are required to replace glandular cells. 226 An important new finding is the expression of survivin, an antiapoptosis protein, in gastric progenitor cells, which allows these cells to avoid apoptosis and promotes mitosis. 
Sensory innervation of gastric mucosa.
Innervation of gastric mucosa and submucosal vessels by primary afferent sensory neurons and nerves forming a dense plexus at the mucosal base facilitates regulation of mucosal blood flow and release of neurotransmitters such as calcitonin gene-related peptide and substance P in the nerve terminals. These neurotransmitters exert a mucosal protective effect via vasodilation of submucosal vessels mediated by NO generation.
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Continuous generation of PGE 2 and PGI 2 . Almost all mucosal defense mechanisms are facilitated by PGs which inhibit acid secretion, stimulate mucus, bicarbonate, and phospholipid secretion, increase mucosal blood flow, and accelerate epithelial restitution and mucosal healing. 231, 232 PGs also inhibit mast cell activation and leukocyte and platelet adherence to the vascular endothelium.
Neurohormonal regulation of gastric mucosal defense. Gastric mucosal defense is regulated
in part by central vagal activation which increases mucus gel and surface cell intracellular pH in rat stomach, 233 and central corticotrophin-releasing factor (CRF) signaling pathways.
GASTRIC MUCOSAL INJURY SECONDARY TO IMPAIRED MUCOSAL DEFENSE
In 1910, Dragutin Schwarz stated, "No acid, no ulcer", and for decades it was accepted that acid was the cause of gastrointestinal (GI) tract ulceration. While important in the pathogenesis of ulceration/erosion, acid is not the only factor responsible. Gastrointestinal ulceration/erosion (GUE) is caused by an imbalance of excessive triggers (e.g., hydrochloric acid, pepsin, bile acids) or deficient mucosal defenses (e.g., gastric mucosal blood flow, mucus production, bicarbonate secretion, epidermal growth hormone, prostaglandins). 234 For example, increased gastric mucosal blood flow can protect against excessive gastric acid secretion, while deficient mucosal blood flow allows otherwise innocuous amounts of acid to produce GUE.
Hence, while gastric pH is a marker for gastroprotection, ignoring the other factors is simplistic and potentially misleading. NSAID-related injury, stress-related mucosal disease (SRMD), and
Helicobacter pylori-associated disease in people are among the most important causes of impaired gastric mucosal barrier function.
NSAID-Related Gastric Injury
Gastric mucosal damage associated with NSAID administration has been well documented in many species, including dogs, cats, and humans. 94, [235] [236] [237] [238] [239] [240] [241] 95 As many as 25% of people who are chronic NSAID users will develop ulcer disease, and 2-4% will bleed or perforate. [242] [243] [244] [245] Risk factors for GI complications associated with NSAIDs in people include increased age > 65 years (odds ratio 4.7), 246 higher doses of NSAIDs (odds ratio 3.9 at 1-1.5 times standard dose), short-term history of NSAID use (< 1 month; odds ratio 12.7), concurrent administration of corticosteroids (odds ratio 4.4), and anticoagulants (odds ratio 12.7). 
Stress-related mucosal disease (SRMD)
Stress-related gastric mucosal injury appears to be related to local ischemia, although progression to significant mucosal injury requires acid as well. Studies in a rat model reveal a significant correlation between blood pressure during hypotension and gastric mucosal blood flow. 258 SRMD occurs in critically ill patients, particularly those suffering from severe trauma, burns > one third of the body surface area, major intracranial disease, major surgery, and severe medical illness. A multicenter study in 2252 human patients revealed only 2 independent risk factors for clinically important stress bleeding: mechanical ventilation for ≥ 48 hours (odds ratio
[OR] 15.6) and coagulopathy (OR, 4.3). 259 Endoscopic studies generally indicate that approximately 75-100% of critically ill human patients have gross gastric lesions visible when endoscopy is performed within the first 1-3 days of illness. 260 Lesions are generally diffuse subepithelial hemorrhage and erosions and occur more commonly in the proximal stomach.
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Although stress-related bleeding has been calculated to increase hospital stay and mortality, studies of prophylactic therapy have not revealed that decreased bleeding translates into decreased mortality.
262

Helicobacter
Overwhelming evidence supports a causal relationship between Helicobacter pylori (HP)
infection and the development of gastric ulceration (GU) and duodenal ulceration (DU) in people. 263, 264 Several studies indicate that 95% of patients with DU and 80% of patients with GU are infected with HP. 264 The most convincing evidence for a casual association between HP and peptic ulcer disease is derived from studying ulcer recurrence rates in patients treated with antibiotics effective for eradicating HP. Compared with patients whose ulcers were healed by H 2 RAs, the patients in whom HP was eradicated by antibiotics showed much lower rate of DU recurrence. 265, 266 
